Garrett Durkan

586 total citations
21 papers, 451 citations indexed

About

Garrett Durkan is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Garrett Durkan has authored 21 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Garrett Durkan's work include Bladder and Urothelial Cancer Treatments (8 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Prostate Cancer Treatment and Research (7 papers). Garrett Durkan is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Prostate Cancer Treatment and Research (7 papers). Garrett Durkan collaborates with scholars based in United Kingdom, Ireland and Canada. Garrett Durkan's co-authors include David E. Neal, Mark Johnson, Barry R. Davies, Marie O’Donnell, Roger Barraclough, Andrew Thorpe, Philip S. Rudland, J. Kilian Mellon, J. F. Cosgrove and Michael J. Kerin and has published in prestigious journals such as PLoS ONE, The Journal of Urology and The Journal of Pathology.

In The Last Decade

Garrett Durkan

18 papers receiving 443 citations

Peers

Countries citing papers authored by Garrett Durkan

Since Specialization

Citations

This map shows the geographic impact of Garrett Durkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garrett Durkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garrett Durkan more than expected).

Fields of papers citing papers by Garrett Durkan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garrett Durkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garrett Durkan. The network helps show where Garrett Durkan may publish in the future.

Co-authorship network of co-authors of Garrett Durkan

This figure shows the co-authorship network connecting the top 25 collaborators of Garrett Durkan. A scholar is included among the top collaborators of Garrett Durkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garrett Durkan. Garrett Durkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A case report of mucinous tubular and spindle cell carcinoma of the kidney. 2023 ·PubMed ·Dara Lundon, B.D. Kelly, (unknown), David Coyle, (unknown), Seán O. Hynes, Teresa McHale, Garrett Durkan	0
2	A critical analysis of deficiencies in the quality of information contained in prostate multiparametric MRI requests and reports 2022 ·Irish Journal of Medical Science (1971 -) ·Orla Cullivan, (unknown), M. Hegazy, (unknown), Garrett Durkan, (unknown), Peter McCarthy, Catherine Dowling	1
3	Strategies to maximise patient comfort during extracorporeal shockwave lithotripsy – A randomised controlled trial 2020 ·The Surgeon ·(unknown), (unknown), (unknown), Eamonn Rogers, Patrick G. O’Malley, (unknown), (unknown), Garrett Durkan, Kilian Walsh, Catherine Dowling, (unknown)	3
4	A risk calculator to inform the need for a prostate biopsy: a rapid access clinic cohort 2020 ·BMC Medical Informatics and Decision Making ·Amirhossein Jalali, Robert W. Foley, (unknown), Keefe Murphy, Dara Lundon, Thomas Lynch, Richard Power, (unknown), (unknown), David Galvin, Garrett Durkan, Thomas Brendan Murphy, R. William G. Watson	14
5	Development of an advanced nurse practitioner led bladder cancer surveillance service in Ireland: Preliminary audit results 2019 ·International Journal of Urological Nursing ·(unknown), Eamonn Rogers, (unknown), Catherine Dowling, Garrett Durkan, Kilian Walsh, (unknown), (unknown), (unknown), (unknown), (unknown)	2
6	Measuring a new facet of post traumatic growth: Development of a scale of physical post traumatic growth in men with prostate cancer 2018 ·PLoS ONE ·Deirdre Walsh, AnnMarie Groarke, Todd G. Morrison, Garrett Durkan, Eamonn Rogers, Francis Sullivan	15
7	Outcomes from the Introduction of a Combined Urology Outpatient Clinic 2018 ·Advances in Urology ·(unknown), Catherine Dowling, (unknown), (unknown), Kilian Walsh, (unknown), Eamonn Rogers, Garrett Durkan, (unknown)	0
8	Increasing detection of significant prostate cancer in younger men - ten year trends in prostate cancer risk profile in the Mid-west of Ireland 2017 ·Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication ·Nikita Bhatt, (unknown), (unknown), (unknown), Garrett Durkan, Hugh D. Flood, Subhasis Giri	2
9	ecancermedicalscience 2016 ·ecancermedicalscience ·Nikhil Vasdev, José L. Domínguez-Escrig, Edgar Páez, Mark Johnson, Garrett Durkan, Andrew Thorpe	16
10	European Randomised Study of Screening for Prostate Cancer ( ERSPC ) risk calculators significantly outperform the Prostate Cancer Prevention Trial ( PCPT ) 2.0 in the prediction of prostate cancer: a multi‐institutional study 2016 ·British Journal of Urology ·Robert W. Foley, (unknown), (unknown), Keefe Murphy, Dara Lundon, Garrett Durkan, Richard Power, (unknown), (unknown), David Galvin, Thomas Brendan Murphy, R. William G. Watson	58
11	Feasibility study of a randomized controlled trial comparing docetaxel chemotherapy and androgen deprivation therapy with sequential prostatic biopsies from patients with advanced non–castration-resistant prostate cancer 2015 ·Urologic Oncology Seminars and Original Investigations ·Prabhakar Rajan, J. Frew, James M. Wilson, Ashraf Azzabi, R. McMenemin, Jacqueline Stockley, Naeem Soomro, Garrett Durkan, Ian Pedley, Hing Y. Leung	4
12	Urinary function and health-related quality of life of patients after laparoscopic radical prostatectomy: two methods of assessment for 112 patients with up to six years of follow-up 2013 ·Journal of Clinical Urology ·(unknown), Nikhil Vasdev, Naeem Soomro, Garrett Durkan	1
13	Oncological outcomes in low-, intermediate- and high D'Amico-risk patients undergoing laparoscopic radical prostatectomy at a single UK centre 2013 ·Journal of Clinical Urology ·(unknown), Nikhil Vasdev, Rajan Veeratterapillay, (unknown), Garrett Durkan, Mark Johnson, Naeem Soomro	2
14	Developing a Laparoscopic Radical Prostatectomy Service: Defining the Learning Curve 2012 ·Journal of Endourology ·Nikhil Vasdev, (unknown), (unknown), (unknown), (unknown), Mark Johnson, Garrett Durkan, Naeem Soomro	9
15	The Role of Early Re-Resection in pTaG3 Transitional Cell Carcinoma of the Urinary Bladder 2011 ·Nikhil Vasdev, (unknown), José L. Domínguez-Escrig, Amira El‐Sherif, Mark Johnson, Garrett Durkan, D. Rix, Andrew Thorpe	5
16	A Double-Blind Randomized Controlled Clinical Trial to Assess the Effect of Doppler Optimized Intraoperative Fluid Management on Outcome Following Radical Cystectomy 2011 ·The Journal of Urology ·(unknown), (unknown), (unknown), Christopher Snowden, Ian Nesbitt, Garrett Durkan, Mark Johnson, J. F. Cosgrove, Andrew Thorpe	101
17	The Influence of High-Grade and Low-Grade Histological Sub-Classification of G2 pT1 Transitional Cell Cancer of Bladder on Tumour Recurrence and Progression Rates—5-Year Retrospective Analysis 2010 ·Matthew Shaw, (unknown), Mark Johnson, Garrett Durkan, Amira El‐Sherif, Andrew Thorpe	0
18	Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer. 2003 ·PubMed ·Garrett Durkan, J E Nutt, Colin Marsh, P. Rajjayabun, Mary Robinson, David E. Neal, John Lunec, J. Kilian Mellon	37
19	Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer 2002 ·The Journal of Pathology ·Barry R. Davies, Marie O’Donnell, Garrett Durkan, Philip S. Rudland, Roger Barraclough, David E. Neal, J. Kilian Mellon	102
20	Urinary Matrix Metalloproteinase-1 (MMP-1) and Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) in Bladder Cancer 1999 ·The Journal of Urology ·Garrett Durkan, J E Nutt, David E. Neal, John Lunec, J. Kilian Mellon	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact